The BclI polymorphism has been linked to increased GC sensitivity and consequently to higher BMI, waist circumference and lipid levels, compared to wild type carriers [11]; however, there are no data about the impact of these NR3C1 polymorphisms on the metabolic profile of CAH patients. The gene discussed is NR3C1; the disease is congenital adrenal hyperplasia.